Milliman Healthcare Inflation Plus ETF

Milliman Healthcare Inflation Plus ETF is an exchange-traded fund designed to help investors address the challenge of rising U.S. healthcare costs by seeking returns that exceed the healthcare inflation rate. It builds on the Milliman Health Trend Guidelines, a series of indices that track the cost, utilization, and unit cost of healthcare services, including professional services, inpatient and outpatient care, and prescription pharmaceuticals. Data for these guidelines comes from leading commercial health insurance plans and data firms covering millions of insured individuals, combined with current economic data to forecast expected claims trends. The ETF employs a diversified portfolio featuring short-term and intermediate Treasuries, gold exposure, S&P 500 elements, and allocations to healthcare companies, with increased emphasis on equities and sectors like pharmaceuticals experiencing higher inflation, such as those related to GLP-1 drugs. Unlike the Milliman Healthcare Inflation Guard ETF, which aims to match healthcare inflation, this Plus version targets outperformance through its enhanced equity tilt. It serves institutional investors like insurance companies managing liabilities and individual retirees concerned about healthcare expenses eroding savings, leveraging Milliman's actuarial expertise in a financial product format. Launched in 2026 and headquartered in the United States, Milliman Healthcare Inflation Plus ETF provides a targeted tool within the ETF market for healthcare cost mitigation.